Wei Ding, MBBS, Ph.D.
Chronic lymphocytic leukemia (CLL) remains an incurable disease and a significant health concern. Most patients responding to therapies eventually relapse. A primary reason for disease relapse is that tissue microenvironments form niches to harbor the residual leukemic cells.
The research of Wei Ding, MBBS, Ph.D., is focused on identifying the key factors in the interaction of leukemic cells with host cells in order to develop novel therapies for relapsed CLL patients.
Significance to patient care
Improved knowledge about the three focus areas above will help in the design of novel therapies for relapsed CLL patients.
Clinician Investigator Fellow
Molecular, Cellular and Developmental Biology
Master of Medicine
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.